Antibiotice S.A. (BVB:ATB)

Market Cap	1.67B
Revenue (ttm)	648.96M
Net Income (ttm)	56.90M
Shares Out	671.34M
EPS (ttm)	0.08
PE Ratio	29.38
Forward PE	n/a
Dividend	0.02 (0.84%)
Ex-Dividend Date	Sep 25, 2025

Volume	120,278
Average Volume	175,899
Open	2.450
Previous Close	n/a
Day's Range	2.450 - 2.505
52-Week Range	1.750 - 2.725
Beta	0.27
RSI	55.98
Earnings Date	Feb 24, 2026

About Antibiotice

Antibiotice S.A. produces and sells medicinal products in Romania and internationally. The company offers generic prescription medicines comprising anti-infectives, including drugs for the treatment of tuberculosis, as well as cardiovascular drugs, digestive tract and metabolism class, preparations for the treatment of gynecological diseases, and dermatological and central nervous system preparations; generic non-prescription medicines, including food supplements, cosmetics, and medical devices; active substances; biofertilizers; biocides for d...

• Industry: Pharmaceutical Preparations
• Founded: 1955
• Employees: 1,357
• Stock Exchange: Bucharest Stock Exchange
• Ticker Symbol: ATB

Financial Performance

In 2024, Antibiotice's revenue was 688.70 million, an increase of 11.93% compared to the previous year's 615.29 million. Earnings were 102.20 million, an increase of 26.04%.